Pnc Financial Services Group, Inc. Denali Therapeutics Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 3,790 shares of DNLI stock, worth $84,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,790
Previous 2,905
30.46%
Holding current value
$84,327
Previous $84,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding DNLI
# of Institutions
234Shares Held
119MCall Options Held
60.6KPut Options Held
48.4K-
Black Rock Inc. New York, NY13.2MShares$293 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$274 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$249 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$239 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$176 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.99B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...